View of EFFICIENCY OF ATORVASTATIN THERAPY FOR DECREASING THE LEVEL OF HIGHLY SENSITIVE C- REACTIVE PROTEIN (HSCRP) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Return to Article Details EFFICIENCY OF ATORVASTATIN THERAPY FOR DECREASING THE LEVEL OF HIGHLY SENSITIVE C- REACTIVE PROTEIN (HSCRP) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Download Download PDF